Lung cancer screening
Revista Ciencia y Salud / eISSN: 2215-4949 / https://revistacienciaysalud.ac.cr/ojs

Vol. 7 No. 4 (2023)Artículos

Vol. 7 No. 4 (2023)

Lung cancer screening: Types and evidence

Artículos

Versions

Supplementary Files

PDF (Español (España))

Keywords

Cáncer de pulmón
Tamizaje
tomografía computarizada de bajas dosis

How to Cite

Zumbado-Morales, R., Fournier Castellot, A. ., Pérez de la Cuesta , S. ., & Sánchez Rodríguez , I. . (2023). Lung cancer screening: Types and evidence . Revista Ciencia Y Salud, 7(4), 129–136. https://doi.org/10.34192/cienciaysalud.v7i4.694

Abstract

The second cancer with the highest incidence and the leading cause of cancer death worldwide is lung cancer. This represents a public health issue in countries with populations at risk of developing this cancer. The main axis to reduce mortality from this cancer is the early detection of this pathology. To achieve this goal, imaging tests such as chest radiography and low dose computed tomography have been studied. The computer tomography is the one that has presented the greatest evidence in reducing mortality and with greater benefits than risks in the population at risk. Blood biomarkers are also being investigated as a method of screening against lung cancer. Despite the existence of evidence on screening methods, there are multiple adversities that can limit access to screening. These adversities are a major problem in the fight against this cancer and should not be underestimated.

https://doi.org/10.34192/cienciaysalud.v7i4.694
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2023 Rodrigo Zumbado-Morales, André Fournier Castellot, Sebastián Pérez de la Cuesta , Ivanovich Sánchez Rodríguez

Downloads

Download data is not yet available.